116 related articles for article (PubMed ID: 2180568)
1. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2.
Koivunen E; Itkonen O; Halila H; Stenman UH
Cancer Res; 1990 Apr; 50(8):2375-8. PubMed ID: 2180568
[TBL] [Abstract][Full Text] [Related]
2. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis.
Itkonen O; Koivunen E; Hurme M; Alfthan H; Schröder T; Stenman UH
J Lab Clin Med; 1990 Jun; 115(6):712-8. PubMed ID: 2366031
[TBL] [Abstract][Full Text] [Related]
3. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
4. Human trypsinogens in the pancreas and in cancer.
Itkonen O
Scand J Clin Lab Invest; 2010 Apr; 70(2):136-43. PubMed ID: 20163205
[TBL] [Abstract][Full Text] [Related]
5. Tumour-associated trypsin inhibitor and tumour-associated trypsin.
Stenman UH
Scand J Clin Lab Invest Suppl; 1990; 201():93-101. PubMed ID: 2244188
[TBL] [Abstract][Full Text] [Related]
6. Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase.
Koivunen E; Huhtala ML; Stenman UH
J Biol Chem; 1989 Aug; 264(24):14095-9. PubMed ID: 2503510
[TBL] [Abstract][Full Text] [Related]
7. Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen.
Koivunen E; Saksela O; Itkonen O; Osman S; Huhtala ML; Stenman UH
Int J Cancer; 1991 Feb; 47(4):592-6. PubMed ID: 1995487
[TBL] [Abstract][Full Text] [Related]
8. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
Menczer J; Ben-Baruch G; Moran O; Lipitz S
Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
[TBL] [Abstract][Full Text] [Related]
9. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
11. GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.
Kolwijck E; Zusterzeel PL; Roelofs HM; Hendriks JC; Peters WH; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2176-81. PubMed ID: 19661073
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
13. Mouse monoclonal antibodies which recognize a human (beta 1-4)galactosyl-transferase associated with tumor in body fluids.
Uemura M; Sakaguchi T; Uejima T; Nozawa S; Narimatsu H
Cancer Res; 1992 Nov; 52(22):6153-7. PubMed ID: 1423258
[TBL] [Abstract][Full Text] [Related]
14. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
16. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
[TBL] [Abstract][Full Text] [Related]
17. Collagenases (MMP-1, -8 and -13) and trypsinogen-2 in fluid from benign and malignant ovarian cysts.
Stenman M; Paju A; Hanemaaijer R; Tervahartiala T; Leminen A; Stenman UH; Konttinen YT; Sorsa T
Tumour Biol; 2003; 24(1):9-12. PubMed ID: 12743421
[TBL] [Abstract][Full Text] [Related]
18. TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
Harłozinska A; Sedlaczek P; Van Dalen A; Rozdolski K; Einarsson R
Anticancer Res; 1997; 17(6D):4473-8. PubMed ID: 9494553
[TBL] [Abstract][Full Text] [Related]
19. Characterization and immunoassay of human tumor-associated galactosyltransferase isoenzyme II.
Uemura M; Winant RC; Sikic BI; Brandt AE
Cancer Res; 1988 Sep; 48(18):5325-34. PubMed ID: 3136919
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy of ovarian and adnexal cyst fluid. A useful adjunct to cytology.
Greenebaum E; Yee HT; Liu J
Acta Cytol; 1994; 38(2):201-8. PubMed ID: 8147211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
